MAintain the Efficacy and Safety in Treatment of Schizophrenia After Switching to Long-acTing Injectable aRipiprazole From Oral Atypical Antipsychotics
Clinical trial NCT03376763 · COMPLETED
Trial details
- NCT number
- NCT03376763
- Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-21
- Primary completion
- 2021-11-19
- Enrollment
- 201
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.